VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CPIX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CPIXCumberland Pharmaceuticals Inc.
$6.84$102M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCPIXQuarterly Financials

Cumberland Pharmaceuticals Inc. (CPIX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Cumberland Pharmaceuticals Inc. (CPIX) quarterly income statement — complete revenue, gross profit & net income history

CPIX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue9.13M13.68M8.29M10.84M11.71M10.44M9.09M9.85M8.5M9.35M10.09M10.89M9.22M9.12M11.41M10.3M11.18M8.32M8.07M9.06M
Revenue Growth %-22.04%31.08%-8.73%10.04%37.84%11.57%-9.92%-9.55%-7.88%2.51%-11.63%5.73%-17.45%9.66%41.38%13.73%6.05%-18.92%-12.74%-5.65%
Cost of Goods Sold1.93M2.24M988.76K2.01M1.43M1.98M1.32M1.71M1.58M1.53M1.77M1.52M1.25M2.65M2.22M2.03M2.21M3.33M1.33M1.74M
COGS % of Revenue21.18%16.39%11.92%18.56%12.17%18.94%14.56%17.37%18.54%16.36%17.51%13.97%13.55%29.05%19.49%19.73%19.79%39.97%16.45%19.22%
Gross Profit7.2M11.44M7.3M8.83M10.29M8.46M7.76M8.14M6.92M7.82M8.32M9.37M7.97M6.47M9.19M8.27M8.96M4.99M6.74M7.31M
Gross Margin %78.82%83.61%88.08%81.44%87.83%81.06%85.44%82.63%81.46%83.64%82.49%86.03%86.45%70.95%80.51%80.27%80.21%60.03%83.55%80.78%
Gross Profit Growth %-30.04%35.21%-5.92%8.46%48.61%8.13%-6.7%-13.13%-13.2%20.85%-9.45%13.32%-11.03%29.61%36.24%13.02%10.39%-37.53%-5.11%4.67%
Operating Expenses10.33M12.81M9.27M9.57M9M10.3M9.46M9.16M8.79M14M10.19M9.35M9.51M8.75M9.48M10.11M10.26M9.35M8.31M8.75M
OpEx % of Revenue113.09%93.64%111.78%88.34%76.8%98.71%104.09%93.05%103.46%149.71%101%85.82%103.05%95.92%83.04%98.2%91.77%112.37%102.92%96.63%
Selling, General & Admin7.62M10.25M7.01M7.1M6.69M7.55M7.07M7.01M6.52M8.2M7.09M7.04M6.78M6.89M6.28M6.76M6.92M6.72M5.84M6.22M
SG&A % of Revenue83.44%74.9%84.49%65.5%57.16%72.34%77.84%71.13%76.76%87.65%70.27%64.67%73.46%75.49%54.99%65.64%61.89%80.75%72.35%68.68%
Research & Development1.46M1.55M1.25M1.47M1.3M1.29M1.31M1.06M1.16M1.26M1.92M1.15M1.5M1.41M1.71M1.82M1.75M1.61M1.45M1.36M
R&D % of Revenue15.97%11.33%15.11%13.55%11.06%12.39%14.38%10.75%13.63%13.52%19.08%10.52%16.26%15.41%15.02%17.71%15.62%19.39%18.01%15.02%
Other Operating Expenses1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K458.22K1000K1000K1000K1000K1000K1000K
Operating Income-3.13M-1.37M-1.97M-747.48K1.29M-1.84M-1.69M-1.03M-1.87M-6.18M-1.87M22.86K-1.53M-2.28M-288.59K-1.85M-1.29M-4.35M-1.56M-1.44M
Operating Margin %-34.27%-10.02%-23.7%-6.9%11.03%-17.65%-18.65%-10.42%-22%-66.07%-18.51%0.21%-16.6%-24.97%-2.53%-17.93%-11.56%-52.33%-19.37%-15.85%
Operating Income Growth %-342.22%25.56%-15.98%27.2%169.12%70.19%9.22%-4591.4%-22.04%-171.28%-546.81%101.24%-18.55%47.68%81.54%-28.61%-298.4%-149.38%-29.35%9.19%
EBITDA-1.85M-44.12K-927.46K571.63K2.61M-60.46K-293.21K397.94K-433.38K-4.11M-379.84K1.52M-103.79K-1.77M1.26M-228.2K361.75K-3.28M-489.73K-207.76K
EBITDA Margin %-20.29%-0.32%-11.18%5.27%22.27%-0.58%-3.23%4.04%-5.1%-43.96%-3.77%13.96%-1.13%-19.36%11%-2.22%3.24%-39.39%-6.07%-2.29%
EBITDA Growth %-171.03%27.02%-216.31%43.65%701.94%98.53%22.81%-73.82%-317.54%-132.77%-130.24%766.05%-128.69%46.1%356.46%-9.84%-59.95%-527.68%-2522.92%47.85%
D&A (Non-Cash Add-back)1.28M1.33M1.04M1.32M1.32M1.78M1.4M1.42M1.44M2.07M1.49M1.5M1.43M511.48K1.54M1.62M1.65M1.08M1.07M1.23M
EBIT-3.13M-1.28M-1.83M-619.99K1.42M-1.74M-1.39M-964.85K-1.77M-6.1M-946.2K1.06M365.58K-2.23M-266.99K-1.22M-1.28M-4.35M-1.56M758K
Net Interest Income-7.81K-20.98K21.88K17.94K-38.09K-116.59K-68.18K-64.51K-21.78K-97.79K-11.48K-135.57K-136.16K-133.76K-127.74K-122.56K-103.53K-21.06K-12.63K-19.27K
Interest Income78.03K91.97K131.58K127.49K125.71K106.67K69.19K61.84K96.75K81K98.6K57.06K50.19K45.7K21.6K15.07K16.04K6.67K7.39K6.59K
Interest Expense85.84K112.94K109.7K109.55K163.8K223.26K137.37K126.35K118.53K178.79K110.08K192.63K186.35K179.46K149.34K137.62K119.58K27.73K20.02K25.86K
Other Income/Expense-7.81K-34.2K21.88K17.94K-38.09K-116.59K168.91K-64.51K-21.78K-97.79K810.32K846.23K1.71M-133.76K-127.74K488.77K-103.53K-21.06K-12.63K2.17M
Pretax Income-3.14M-1.41M-1.94M-729.54K1.25M-1.96M-1.53M-1.09M-1.89M-6.28M-1.06M869.09K179.22K-2.41M-416.33K-1.36M-1.4M-4.38M-1.58M732.14K
Pretax Margin %-34.36%-10.27%-23.44%-6.73%10.7%-18.77%-16.79%-11.08%-22.25%-67.11%-10.47%7.98%1.94%-26.43%-3.65%-13.18%-12.49%-52.59%-19.52%8.09%
Income Tax3.87K23.25K5.67K5.67K5.67K-57K11.44K11.44K11.44K24.96K6.94K6.94K6.94K48.15K6.9K6.9K6.9K12.52K7.46K7.46K
Effective Tax Rate %-0.12%-1.65%-0.29%-0.78%0.45%2.91%-0.75%-1.05%-0.61%-0.4%-0.66%0.8%3.87%-2%-1.66%-0.51%-0.49%-0.29%-0.47%1.02%
Net Income-3.14M-1.41M-1.94M-740.74K1.26M-1.9M-1.54M-1.09M-1.95M-6.29M-1.05M872.2K192.18K-2.44M-408.64K-1.34M-1.39M-3.85M-1.06M1.23M
Net Margin %-34.37%-10.32%-23.4%-6.84%10.73%-18.24%-16.99%-11.02%-22.9%-67.3%-10.4%8.01%2.08%-26.75%-3.58%-12.97%-12.4%-46.25%-13.07%13.57%
Net Income Growth %-349.66%25.85%-25.69%31.77%164.59%69.75%-47.15%-224.47%-1112.71%-157.89%-156.78%165.3%113.87%36.57%61.28%-208.71%-930.35%-335.37%-119.06%233.79%
Net Income (Continuing)-3.14M-1.43M-1.95M-735.21K1.25M-1.9M-1.54M-1.1M-1.9M-6.3M-1.06M862.15K172.29K-2.46M-423.23K-1.36M-1.4M-4.39M-1.58M724.68K
Discontinued Operations00000000000000000503.32K496.79K498.81K
Minority Interest-333.51K-336.1K-319.15K-310.87K-316.4K-307.52K-309.69K-316.81K-299.78K-343.57K-335.99K-322.07K-312.02K-292.13K-273.14K-258.55K-229.51K-212.33K-175.77K-144.35K
EPS (Diluted)-0.22-0.09-0.13-0.050.08-0.14-0.11-0.08-0.14-0.44-0.070.060.01-0.17-0.03-0.09-0.09-0.26-0.070.08
EPS Growth %-375%32.57%-18.18%37.5%157.14%68.18%-57.14%-233.33%-1500%-158.82%-133.33%166.67%111.11%34.62%57.14%-212.5%-1000%-333.33%-120.13%232.89%
EPS (Basic)-0.22-0.09-0.13-0.050.08-0.14-0.11-0.08-0.14-0.44-0.070.060.01-0.17-0.03-0.09-0.09-0.26-0.070.08
Diluted Shares Outstanding14.96M14.96M14.95M14.96M15.26M13.97M14.05M14.12M14.1M14.16M14.28M14.55M14.59M14.4M14.48M14.69M14.69M14.8M14.88M15.11M
Basic Shares Outstanding14.96M14.96M14.95M14.96M14.94M13.97M14.05M14.12M14.1M14.16M14.28M14.39M14.36M14.4M14.48M14.69M14.69M14.8M14.88M14.98M
Dividend Payout Ratio--------------------